Sign in
Taking people in United StatesNo phase

Group Training Program for Teens with Chronic Sickle Cell Pain

Tests a group program teaching mind and body skills to teens with sickle cell pain.

Key facts

Who runs it
Emory University
Where
Atlanta, Cincinnati, and Hartford, United StatesSee the 4 sites
Trial code
Registry title
Integrative Training Program for Pediatric Sickle Cell Pain
Status
Recruiting
People taking part
155 people, planned
Started
8 Jan 2025
Expected to end
Aug 2027
Type of study
Interventional, 2 groups
Treatments tested
  • I-STRONG
  • Enhanced Usual Care (EUC)
Record updated
14 November 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for teens aged 12-18 with sickle cell disease and ongoing pain. It tests a group program that teaches mind and body skills to ease pain. Caregivers also take part.

Age
12 to 18 years for teens. Caregivers have no age limit.
Sex
Males and females can join.
Disease stage
Documented sickle cell disease of any genotype. Teens score at least 3 on the Pediatric Pain Screening Tool. Typical pain in the past week is at least 4 on a 0-10 cm (0–3.9 in) Visual Analog Scale.
Earlier treatment
If a teen takes disease-modifying treatment (for example hydroxyurea, glutamine, voxelotor, crizanlizumab), it must be stable: not newly started or clearly increased in the past 3 months. Teens in weekly non-drug pain therapy that overlaps with the program cannot join.

Main reasons for not taking part

  • Pain-related medical conditions not caused by sickle cell disease (for example rheumatologic disorders or inflammatory bowel disease)
  • Past genetic or hematopoietic stem cell therapy
  • Currently in active non-drug pain treatment, such as weekly behavioral pain management, physical therapy or acupuncture, that overlaps with the program
  • A physical or psychological condition or exam finding that prevents taking part
  • Cannot speak and read English

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Provision of signed and dated informed consent form for adolescents 18 years old and caregivers' participation
  • For children <18, informed assent and parental informed consent to participate in the study
  • Willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study
  • Males and females; Ages 12-18 years for adolescents; no age limitations for caregivers
  • Documented diagnosis of sickle cell disease (any genotype) for adolescents
  • Adolescent scores at least 3 on the Pediatric Pain Screening Tool
  • Adolescent reports typical pain intensity in the past week at least 4 on a 0-10 cm Visual Analog Scale
  • Adolescent on stable disease-modifying treatments, if applicable (e.g., hydroxyurea, glutamine, voxelotor, crizanlizumab) as defined by not newly initiated or significantly increased dosages (mg/kg) in the past 3 months
  • Speak and read English

Who cannot take part

  • Adolescent has undergone genetic or hematopoietic stem cell therapy
  • Adolescents receiving active treatment (e.g., weekly appointments with a provider) for nonpharmacological therapies (e.g., structured behavioral pain management, physical therapy, or acupuncture program) that overlap with the active phase of the study intervention
  • An adolescent has comorbid medical conditions typically associated with pain but unrelated to SCD (e.g., rheumatologic disorders or inflammatory bowel disease)
  • Presence of a condition(s) or diagnosis, either physical or psychological, or physical exam finding that precludes participation

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 12 and 18 years old?

Where in United States

  • Arthur M Blank Hospital - Children's Healthcare of AtlantaAtlanta, United StatesContact: Soumitri Sil, PhD, ABPPTaking people
  • Children's Healthcare of AtlantaAtlanta, United StatesContact: Soumitri Sil, PhD, ABPPTaking people
  • Cincinnati Children's Hospital Medical CenterCincinnati, United StatesContact: Soumitri Sil, PhD, ABPPTaking people
  • Connecticut Children's Medical CenterHartford, United StatesContact: Soumitri Sil, PhD, ABPPTaking people

About the trial

What the trial wants to find out

This research aims to answer the question: does a group training program specifically for teens with chronic sickle cell disease (SCD) pain that teaches skills to strengthen the mind and body help improve everyday functioning and reduce pain symptoms?

Read full original descriptionShow less

The program will be tailored to address challenges related to frequent or chronic sickle cell pain and may improve participants' physical and emotional health.

The program, called I-STRONG for SCD (Integrative Strong Body and Mind Training for Sickle Cell Disease), may help improve everyday functioning and pain symptoms in teens with chronic pain related to SCD. The research team aims to determine how participants (teens and parents) respond to this program.

The 2 groups in the trial

  • I-STRONG - Early StartTreatment being tested

    Youth and caregivers will receive the I-STRONG for SCD intervention in addition to standard care.

    Treatment: I-STRONG

  • Enhanced Usual Care (EUC)Other group

    Participants randomized to EUC will continue with standard care and optimal management of their SCD and chronic pain for approximately 8 months. After completing the 6-month follow-up assessment, participants will have the opportunity to start the I-STRONG SCD intervention.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Integrative Strong Body and Mind Training for Pediatric Sickle Cell Pain (I-STRONG for SCD): Multi-site, Randomized Clinical Trial
Plain-language title
Group Training Program for Teens with Chronic Sickle Cell PainGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06691867, who can take part
Record updated
14 November 2025